Former Kantar Health executive and creator of one of the first online physician communities will help Konovo accelerate its mission to transform life science market research
WATERTOWN, MA, September 30, 2025 — Konovo, a technology-first healthcare intelligence company, today announced the appointment of healthcare technology pioneer Jeremy Brody as a board advisor. With a 30-year track record of innovation in market research and health data technologies, Brody will help Konovo to accelerate the expansion of its AI-native intelligent platform.
Presently Managing Director of Brody Capital & Advisors (BC&A), Brody brings deep industry expertise to Konovo’s mission of applying AI in ways that connect fragmented data to develop valuable and comprehensive insights.
Prior to founding BC&A, Brody spent over 12 years at Kantar Health, including as Chief Strategy Officer, where he was a key member of the executive team helping to lead the company’s growth into oncology, rare diseases, and Real-World Evidence (RWE) domains. He also served as Executive Vice President of Corporate Development in charge of partnerships and acquisitions, and as global head of operations.
Early in his career, Brody co-founded Jstreetdata.com, one of the first online physician research panel companies, serving as its Chief Executive Officer through its rapid growth and acquisition in 2002. Brody also served as Chief Strategy Officer at Cerner Enviza following its acquisition of Kantar Health, and at Aetion, a Real-World Evidence technology platform company.
“We’re honored to have Jeremy Brody’s guidance on accelerating innovation through technology, and his depth of understanding of both the challenges and opportunities in life science market research,” said Tal Rosenberg, CEO of Konovo. “His experience and insights will benefit Konovo immensely as we expand our AI-native intelligent platform so that healthcare and life science players can make better decisions at the speed of business today.”
“Konovo is driving long-overdue transformation in the life science market research industry with AI solutions that help organizations connect fragmented data, enabling them to act with clarity and confidence,” said Jeremy Brody. “The company is well-positioned to revolutionize the way life science insights are generated, with leadership that has the vision and the commitment to get the job done.”
About Konovo
Konovo is a global healthcare company on a mission to transform research through technology. Konovo simplifies the research process, connects fragmented insights, and enhances access to hard-to-reach healthcare professionals.
Konovo supports leading market research agencies, consultancies, and pharmaceutical and healthcare brands, by connecting them to specialized healthcare audiences— physicians, KOLs, patients, caregivers, payers, and allied healthcare professionals—via an intelligent platform. Konovo builds on a long history of success in research through the merger of InCrowd, Survey Healthcare Global (SHG), and GlocalMind that was formerly known as Apollo Intelligence. Operating across the Americas, Europe, and Asia, Konovo connects the industry to an extensive network of audiences, partners, and data, enabling deeper, more actionable insights across healthcare. Konovo is a portfolio company of Frazier Healthcare Partners. To learn more, visit www.konovo.com
Contact
Nemesh Patel
VP, Marketing
[email protected]
+1-617-875-8177
Mary Kae Marinac
PR Representative for Konovo
[email protected]
+1 978-685-3136
